Acceptance and well-being in adolescents and young adults with cystic fibrosis: a prospective study by Casier, Annabelle et al.
Acceptance and well-being in adolescents and young adults with cystic fibrosis: a 
prospective study 
Annabelle Casier, MA1,2*, Liesbet Goubert, PhD1,2, Marleen Theunis, MA 3, Danielle Huse, 
MA4,  Frans De Baets, PhD 5, Dirk Matthys, PhD5, Geert Crombez, PhD1,2 
 
1 Department of Experimental-Clinical and Health Psychology 
 Ghent University 
Ghent 
 Belgium 
2 Research Institute for Psychology and Health 
 Utrecht 
 The Netherlands 
3 University Hospital Ghent 
 Cystic Fibrosis Centre 
Ghent 
Belgium 
4 Belgian Cystic Fibrosis Association  
 Brussels 
 Belgium 
5 University Hospital Ghent 
Department of Pediatrics  
Ghent 
Belgium 
 
 
PDF processed with CutePDF evaluation edition www.CutePDF.com
* Corresponding author: Annabelle Casier, Department of Experimental-Clinical and Health 
Psychology, Ghent University, Henri Dunantlaan 2, 9000 Ghent, Belgium. Tel: +32 (0)9 264 
86 12, Fax: +32 (0)9 264 64 89, E-mail address: Annabelle.Casier@Ugent.be.  
 
Acknowledgements 
 
This work was supported by the Belgian Cystic Fibrosis Association (A06/0536). The 
authors want to thank all adolescents and their parents for their cooperation in this study, Prof. 
Dr. Kristine Desager, Prof. Dr. Anne Malfroot, Alexandra Saey, and Gwendolyn Van 
Cauwelaert for their help in recruiting, and Eline Vercaemer and Ilke Corneilli for their help 
with collecting the data. 
 
 1 
Acceptance and well-being in adolescents and young adults with cystic fibrosis: a prospective 
study 
 
Abstract 
Objective: To prospectively investigate the role of acceptance in well-being in adolescents 
and young adults with cystic fibrosis. 
Method: Forty adolescents and young adults with cystic fibrosis (ages 14-22) completed 
questionnaires assessing acceptance, anxiety and depressive symptoms, physical functioning, 
role functioning, emotional functioning, and social functioning. After six months, 28 of them 
completed the questionnaires on anxiety and depressive symptoms, physical functioning, role 
functioning, emotional functioning, and social functioning a second time.  
Results: More acceptance (Time 1) was related to less depressive symptoms (Time 1 and 2), 
and to better role, emotional, and social functioning (Time 1). 
Conclusions: Results indicate that accepting the limitations imposed by chronic disease and 
readjusting life goals may have a positive effect upon well-being in adolescents and young 
adults with cystic fibrosis. Further research is needed to clarify whether acceptance-based 
interventions are useful in promoting well-being in adolescents and young adults with cystic 
fibrosis. 
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Introduction 
Cystic fibrosis (CF) is the most common life-shortening genetic disease amongst the 
Caucasian population, affecting 1 in 2500 newborn children (Cystic Fibrosis Worldwide, 
2005; Ratjen & Döring, 2003). The disease is marked by an increased viscosity of the 
exocrine secretions throughout the body. These hyper viscous secretions mainly affect the 
lungs and the pancreas by plugging the airways and pancreatic ducts. Mucus plugging then 
triggers recurrent cycles of infection and inflammation what results in irreversible tissue 
damage (Ratjen & Döring, 2003; Rosenstein & Zeitlin, 1998). Given the physical 
consequences of the disease, CF also has negative consequences on other domains of 
functioning (Glasscoe & Quittner, 2008).  
Due to substantial improvements in specialised care, almost half of the children and 
adolescents with CF nowadays survive into adulthood (Cystic Fibrosis Foundation, 2010). As 
a consequence, attention to their long-term well-being has become increasingly important 
(Badlan, 2006; Glasscoe & Quittner, 2008). Well-being refers to a broad area of experiences 
that encompasses positive and negative affect, general life satisfaction, and satisfaction with 
specific domains of life (Diener, 1984; Diener, Suh, Lucas, & Smith, 1999). With regard to 
well-being, adolescents and young adults with CF seem to be confronted with two major 
challenges: managing the affective impact of CF and maintaining a satisfactory life (Glasscoe 
& Quittner, 2008; Quittner et al., 2008; Schwartz & Drotar, 2009). Crucial in handling these 
challenges is to balance the limitations (e.g., functional disability) and demands of having CF 
(e.g., disease management) with the pursuit of important developmental goals in order to 
pass on to adulthood (e.g, planning for the future, becoming independent, forming close 
relationships, preparing for a job, making decisions about family life, becoming socially 
responsible, and moving away from home) (Badlan, 2006; Gjengedal et al., 2003; Glasscoe 
& Quittner, 2008; Schwartz & Drotar, 2009). Examples of this balance may be the 
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adjustment of developmental goals that have become unrealistic due to CF (e.g., working 
part-time instead of full-time, postpone university studies and first get health back on track, 
only going out in non-smoking places) or the integration of disease management and 
important developmental goals (e.g., doing aerosol therapy while studying). For individuals 
with CF, adolescence is a particularly challenging period as from then on the limitations 
and demands of having CF typically increase (Ernst et al., 2010). Therefore, it is 
essential to understand how adolescents and young adults with CF maintain their well-
being despite the growing burden of having CF. 
Despite the finding that the challenges of having CF can severely impact upon well-
being (Glasscoe & Quittner, 2008; Quittner et al., 2008; Riekert, Bartlett, Boyle, Krishnan, & 
Rand, 2007; Schwartz & Drotar, 2009), research has shown that not all individuals with CF 
struggle to maintain well-being. Indeed, while some research findings indicate that 
adolescents and young adults with CF experience difficulties in several components of well-
being such as elevated levels of depression (Quittner et al., 2008), elevated levels of anxiety 
(Pfeffer, Pfeffer, & Hodson, 2003), and an affected quality of life (Goldbeck & Schmitz, 
2001; Pfeffer et al., 2003), other findings indicate no significant differences between 
adolescents and young adults with and without CF (Anderson, Flume, & Hardy, 2001; 
Bregnballe, Thastum, & Schiotz, 2007; Goldbeck & Schmitz, 2001; Havermans, Colpaert, & 
Dupont, 2008; Pfeffer et al., 2003; Szyndler, Towns, van Asperen, & McKay, 2005). Hence, 
understanding why certain adolescents and young adults maintain their well-being despite the 
burden of CF is of utmost importance.     
A process that may account for the individual variability in well-being is acceptance. 
Acceptance can be defined as “recognizing the need to adapt to chronic illness while 
perceiving the ability to tolerate the unpredictable, uncontrollable nature of the disease and 
handle its averse consequences” (Evers et al., 2001, p.1027). Acceptance thus comprises the 
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ability to reconcile to the limitations the disease/illness involves, and to face the variable 
demands imposed by the disease, while staying engaged in a valuable life (Badlan, 2006; 
Evers et al., 2001; Gjengedal et al., 2003). As CF is an incurable disease with concomitant 
limitations, acceptance may be a key factor in the well-being of affected individuals (Ernst, 
Johnson, & Stark, 2010).  
The role of acceptance in well-being has already been examined in several chronic 
conditions. Among adults with chronic pain (e.g., McCracken, Carson, Eccleston, & Keefe, 
2004; McCracken & Vowles, 2008; McCracken & Zhao-O’Brien, 2010; Viane et al., 2003), 
cancer pain (Gauthier et al., 2009), chronic fatigue syndrome (Van Damme, Crombez, Van 
Houdenhove, Mariman, & Michielsen, 2006), tinnitus (Westin, Hayes, & Andersson, 2008), 
and multiple sclerosis (Evers et al., 2001; Pakenham, 2006), acceptance was significantly 
associated with positive outcomes such as less anxiety and depression, better mood, better 
emotional, social, and physical functioning, less physical complaints, better work status, and 
less disability. To our knowledge, only one study examined acceptance in adolescents and 
young adults with CF, demonstrating that acceptance was related to less anxiety, depression 
and disability (Casier et al., 2008). This study, however, was cross-sectional and did not 
focus on well-being in general. The present study extends this research by investigating the 
long-term effects of acceptance on well-being. Identifying the effects of acceptance on well-
being over time is important as it may point to processes that promote a valuable and 
meaningful life in the context of a life-shortening illness (Ernst et al., 2010). Furthermore, 
investigating the associations between acceptance and well-being may provide indications 
whether acceptance-based interventions (Hayes, 2004; Hayes et al., 2006) are useful for the 
preservation and enhancement of these adolescents’ and young adults’ well-being, and, if so, 
these findings may further guide the development of these interventions in the context of CF 
(Hayes, 2004; Hayes et al., 2006).  
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Well-being was operationalised in terms of anxiety and depressive symptoms, and 
health-related quality of life. These are important components of well-being, and can be 
detrimentally affected in individuals with CF (Anderson et al., 2001; Diener et al., 1999; 
Pfeffer et al., 2003; Quittner et al., 2008; White, Miller, Smith, & McMahon, 2009). In line 
with expert consensus, health-related quality of life was operationalised as a subjective 
construct that fundamentally includes four core domains: physical functioning, emotional 
functioning, social functioning, and role functioning (Cella, 1998; Spilker, 1996). We 
hypothesized that higher levels of adolescents’ and young adults’ acceptance at Time 1 are 
related to less anxiety and depressive symptoms, and to better physical, emotional, social, and 
role functioning at both Time 1 and 2 (6 months later) (see Evers et al., 2001; McCracken, et 
al., 2004; Pakenham, 2006).  
Method 
Participants 
All adolescents and young adults with CF attending the University Hospitals of 
Antwerp, Brussels, or Ghent, and the Sint-Vincentius Hospital, Antwerp, Belgium who were 
14-22 years of age and met the following criteria were invited to participate: understanding 
the Dutch language, no developmental disorder, and no (planned) lung transplantation. 
Adolescents and young adults who had/were awaiting lung transplantation were not included 
as they find themselves in a situation that is very different from the situation of individuals in 
the pre-transplant period (e.g., very high level of symptoms, being terminally ill, 
intertwinement of end of life issues and hope of transplantation, risk of post-transplant 
complications, dramatic change of illness status) (Bourke et al., 2009; Kurland & Orenstein, 
2001). Seventy-three adolescents and young adults met these criteria. The participating 
centres did not contact 9 of these adolescents and young adults because they had serious 
physical and/or psychosocial problems. Sixty-four adolescents and young adults were invited 
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to participate by letter and/or approached during routine clinic visits by the psychologist from 
the respective hospital (time period of recruitment: 13 months). Subsequently, adolescents 
and young adults agreeing to participate were contacted by phone by a research assistant. 
Forty adolescents and young adults (23 boys; 17 girls) were enrolled in our study (response 
rate = 62.50 %). The main reasons for not participating were a lack of time or motivation (N 
= 14), too many requests for participating in scientific research (N = 7), and not wanting to be 
unnecessarily confronted with the disease (N = 2). Mean age was 18.40 years (SD = 2.87). To 
determine disease severity, the US CF Foundation guidelines for severity of lung disease 
were used (Cystic Fibrosis Foundation, 2008). Disease severity ranged from not 
severe/normal lung function (FEV1% predicted ≥ 90%) to severe (FEV1% predicted < 40%). 
Mean disease severity indicated mild lung disease (M FEV1% = 83.01%). Of all adolescents 
and young adults, 32.50% had normal lung function (FEV1% predicted ≥ 90%), 42.50% mild 
lung disease (89% ≥ FEV1% predicted ≥ 70%), 22.50% moderate lung disease (69% ≥ 
FEV1% predicted ≥ 40%), and 2.5% had severe lung disease (FEV1% predicted < 40%). 
Mean time since diagnosis was 16.84 years (SD = 3.82). All adolescents and young adults 
were of Caucasian origin. Because of confidentiality, no data about the characteristics of the 
non-participants were available. 
Procedure 
At time 1, a research assistant visited the participants at their home. During this house 
visit, written parent consent and/or adolescents and young adult assent/consent were 
obtained, and a booklet of questionnaires (assessing acceptance, anxiety, depression, and 
health-related quality of life) were filled out. At Time 2, all adolescents and young adults 
were contacted again and asked to complete follow-up questionnaires (assessing anxiety, 
depression, and health-related quality of life). The follow-up questionnaires were sent by 
mail. Twenty-eight of the 40 adolescents and young adults (70%) returned the Time 2 
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questionnaires. Drop-out analyses showed that there were no significant differences in age 
(t(38) = -1.03, ns), disease severity (t(38) = -.61, ns), acceptance (t(38) = -1.48, ns), anxiety 
(tanxiety(38) = .64, ns), depression (tdepression(38) = 1.13, ns), and health-related quality of life 
(tphysical functioning(38) = -.98, ns; trole functioning(38) = -1.08, ns; temotional functioning(38) = -1.91, ns; 
tsocial functioning(38) = -.92, ns) between the adolescents and young adults who responded at 
Time 2 and those who did not. This study was approved by the ethical committees of the 
University Hospitals of Antwerp, Brussels, and Ghent, and the Sint-Vincentius Hospital, 
Antwerp and was carried out in accordance with universal ethical principles (Emanuel, 
Wendler, & Grady, 2000). 
Measures 
Acceptance was assessed by the Dutch version of the Illness Cognition Questionnaire 
(ICQ; Evers et al., 2001). This 18-item questionnaire contains 3 subscales: ‘acceptance’, 
‘helplessness’, and ‘perceived benefits’. Only the acceptance scale was used. Acceptance is 
conceptualised as the perceived ability to live with the illness and to master its negative 
consequences (6 items, e.g. “I can handle the problems related to my illness”). Items are rated 
on a 4-point Likert scale (1 = ‘not at all’, 4 = ‘completely’). The total score for acceptance 
varies between 6 and 24, with higher scores indicating higher levels of acceptance. 
Psychometric research in samples of Dutch-speaking adults with rheumatoid arthritis, 
multiple sclerosis, chronic pain and chronic fatigue demonstrated the adequate reliability and 
validity of the ICQ (Evers et al., 2001; Lauwerier et al., 2010). Reliability of the acceptance 
scale in this sample was good with a Cronbach’s α of .90 (see Table 1). 
Health-related quality of life was assessed by the Dutch version of the Cystic Fibrosis 
Questionnaire-Revised Teen/Adult Version (CFQ-R Teen/Adult Version; Klijn et al., 2004; 
Quittner, Modi, Watrous, & Davis, 2003). The CFQ-R Teen/Adult Version consists of 50 
items assessing 9 quality of life domains and is sensitive to the specific concerns of 
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individuals (aged 14 and older) with CF: ‘physical functioning’, ‘role functioning’, ‘vitality’, 
‘emotional functioning’, ‘social functioning’, ‘body image’, ‘eating’, ‘treatment burden’, and 
‘overall health perception’. The CFQ-R Teen/Adult Version also assesses three symptom 
scales: ‘weight’, ‘respiratory’, and ‘digestion’. Because no higher order summary scores are 
available, only the subscales measuring the core domains of health-related quality of life were 
included. In line with expert consensus (Cella, 1998; Spilker, 1996), the following subscales 
were used: physical functioning (8 items, e.g. “Difficulty to walk as fast as others”), role 
functioning (4 items, e.g. “Trouble keeping with school, work or daily activities”), emotional 
functioning (5 items, e.g. “Felt worried”), and social functioning (6 items, e.g. “Stayed at 
home more than you wanted) (Quittner  et al., 2003; Quittner, Buu, Messer, Modi, & 
Watrous, 2005). Items are rated in terms of a frequency response on a 4-point Likert scale (1 
= ‘all the time’, 4 = ‘never’), a difficulty rating on a 4-point Likert scale (1 = ‘a lot of 
difficulty’, 4 = ‘no difficulty’), a true-false response on a 4-point Likert scale (1 = ‘very true’, 
4 = ‘very false’), or a selection of a particular statement (4- or 5-point Likert scale). Total 
scores vary from 0 to 100, with higher scores representing better quality of life (Quittner et 
al., 2000). Reported psychometric properties of the CFQ-R Teen/Adult Version subscales 
were average to good (Quittner et al., 2003). In the current sample, the internal consistencies 
(Cronbach’s α) at Time 1 were .92 for physical functioning, .81 for role functioning, .63 for 
emotional functioning, and .44 for social functioning. Internal consistencies (Cronbach’s α) at 
Time 2 were .84 for physical functioning, .37 for role functioning, .55 for emotional 
functioning, and .60 for social functioning (see Table 1). 
The Dutch version of the Hospital Anxiety and Depression Scale (HADS; Spinhoven 
et al., 1997; Zigmond & Snaith, 1983) was used to assess anxiety and depressive symptoms. 
The HADS consists of 14 items to be rated on a 4-point Likert scale, and has two subscales: 
‘anxiety’ (7 items, e.g. “Do you feel tense and wound up?”) and ‘depression’ (7 items, e.g. 
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“Do you feel cheerful?”). Total scores range between 0 and 21, with higher scores indicating 
higher levels of anxiety and/or depressive symptoms (Snaith, 2003). For depression, scores 
between 7 and 9 are indicative of possible depression, scores above 9 of probable depression. 
Cut-off scores for anxiety are 9 (possible emotional disorder) and 12 (probable emotional 
disorder) (White, Leach, Sims, Atkinson, & Cottrell, 1999). The HADS is designed for use in 
medical practice. It is proven reliable and valid as a screening instrument in adolescents, 
adults, and elderly subjects with or without a medical condition (Spinhoven et al., 1997; 
White et al., 1999; Zigmond & Snaith, 1983). Cronbach’s α in this study for anxiety was .71 
at Time 1 and 2. For depression Cronbach’s α  was .73 at Time 1 and .76 at Time 2 (see 
Table 1). 
Disease severity was determined by using forced expiratory volume in one second 
(FEV1% predicted). FEV1% predicted was taken from the medical chart of each adolescent or 
young adult. The most recent pulmonary function test before the administration of the 
questionnaires was selected (Mdays = 35.56, SD = 27.29, range 1 – 106 days).  Pulmonary 
function tests are the standard for measuring respiratory functioning and lung damage for 
individuals with cystic fibrosis. FEV1% predicted, was used as a continuous variable, with 
lower values indicating poorer respiratory functioning and more lung disease (Ramsey & 
Boat, 1994). Tests were carried out by trained and experienced medical personnel, using a 
Jaeger MasterScreen TM Body (CareFusion Germany 234 GmbH, Hoechberg, Germany). 
During this procedure, individuals are seated in a glass cabin where they perform inspiratory 
and expiratory manoeuvres through a mouthpiece (CareFusion, 2009). 
Socio-demographic information (age, gender and time since diagnosis) was verbally 
inquired before administration of the questionnaires. 
Statistical analyses 
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All analyses were performed using SPSS 15.0. Tests of normality were performed for 
all continuous variables. Descriptive statistics were computed for all variables of interest. 
Pearson’s correlations were performed to determine whether age, time since diagnosis, 
disease severity and acceptance were related to anxiety and depressive symptoms, and health-
related quality of life. Furthermore, t-tests were performed to examine gender differences in 
anxiety and depressive symptoms, and/or health-related quality of life, and to identify 
potential differences between the Time 1 and Time 2 dependent variables. 
Separate hierarchical regression analyses were used to investigate the role of 
acceptance (Time 1) in anxiety and depressive symptoms (Time 1 and 2) and health-related 
quality of life (Time 1 and 2). For regressions with the dependent variable measured at Time 
1, socio-demographic and disease-related variables that were significantly related to the 
outcome measures were entered as control variables in a first step. Acceptance was entered in 
the second step. Anxiety and depressive symptoms, and physical, role, emotional, and social 
functioning at Time 1 were entered as dependent variables. For regressions with the 
dependent variable measured at Time 2, socio-demographic and disease-related variables that 
were significantly related to the outcome measures were entered as control variables in a first 
step. In the second step, we controlled for the corresponding Time 1 measure of respectively 
anxiety and depressive symptoms, and physical, role, emotional, and social functioning. In 
the third step, acceptance was entered. Anxiety and depressive symptoms, and physical, role, 
emotional, and social functioning measured at Time 2 were used as dependent variables. As 
we had a priori hypotheses about the direction of effects, one-tailed tests of significance were 
used (Kline, 2004; Martin & Bateson, 1993, 2007; Wonnacott & Wonnacott, 1985). Alpha 
level was set at p < .05.  To control for multiple testing and balance the amount of type I and 
type II errors, the Benjamini and Hochberg false discovery rate (i.e., the expected proportion 
of rejected true null hypothesis among rejected hypotheses) was used (Benjamini & 
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Hochberg, 1995; Benjamini, Krieger, & Yekutieli, 2006). The False Discovery Rate level 
was set at 5%, assuring that in each set of hierarchical regression analyses (i.e., analyses at 
Time 1 and at Time 2) no more than 5% of the significant relationships found are false-
positive (Benjamini et al., 2006).  
The initial sample (N = 40) had sufficient power (.86) to detect large effects (see 
Casier et al., 2008) in multiple regressions (f² = .35) with 3 variables. The second sample (N 
= 28) had a power of .65 to detect large effects in multiple regressions (f² = .35) with 3 
variables (Vacha-Haase & Thompson, 2004). 
Results 
Descriptive statistics 
Means, standard deviations, and internal consistencies (Cronbach’s α) of variables are 
reported in Table 1. The mean score for acceptance was 18.55 (SD = 4.16), which is in line 
with a previous study on acceptance in adolescents and young adults with CF (Casier et al., 
2008). Mean scores for anxiety and depressive symptoms were indicative of low 
psychological distress. At Time 1, 85 % of the adolescents and young adults scored beneath 
the cut-off for probable anxiety, and 97.50 % beneath the cut-off for probable depression 
(White et al., 1999). The percentage of adolescents and young adults scoring beneath this cut-
off at Time 2 was 88.90 % for anxiety and 96.30 % for depression. Mean levels of physical, 
role, emotional, and social functioning varied between 71.39 and 85.71. Paired sample t-tests 
revealed that there were no significant differences between the Time 1 and Time 2 dependent 
variables. Tests of normality revealed that none of the variables included were skewed. 
Identification of relevant control variables 
Correlations between age, time since diagnose, disease severity, acceptance and 
anxiety and depressive symptoms, and health-related quality of life are reported in Table 1. 
Socio-demographic and disease-related variables that were significantly related to the 
 12 
outcome measures were entered as control variables in the hierarchical regression analyses. 
Furthermore, t-tests revealed that gender was related to emotional functioning at Time 1 
(Mmale = 78.84, SDmale = 13.43; Mfemale = 67.84, SDfemale = 19.18; F(1,38) = 4.56, p < .05), and 
to social functioning at Time 1 (Mmale = 75.85, SDmale = 11.68; Mfemale = 65.36, SDfemale = 
17.07; F(1,38) = 5.33, p < .05). 
Role of acceptance (Time 1) in anxiety and depressive symptoms (Time 1 and 2) 
Table 2 summarizes the results of the multiple regression analyses. As none of the 
socio-demographic and disease-related variables were significantly related to anxiety and 
depressive symptoms, these variables were not included in the analyses. More acceptance 
was significantly related to less anxiety symptoms at Time 1 (β = -.29, t = -1.86, p < .05, 95% 
CI [-.51, .02]). Contrary to our expectations, no significant association was found between 
acceptance at Time 1 and anxiety symptoms at Time 2. Overall, acceptance explained an 
additional variance of 8% in anxiety symptoms at Time 1 (Fchange (1, 38) = 3.46, p < .05). 
Furthermore, more acceptance was significantly related to less depressive symptoms at Time 
1 (β = -.35, t = -2.33, p < .05, 95% CI [-.33, -.02]), and less depressive symptoms at Time 2 
(β = -.31, t = -1.71, p ≤ .05, 95% CI [-.56, .05]). Overall, acceptance explained an additional 
variance of 13% in depressive symptoms at Time 1 (Fchange (1, 38) = 5.43, p < .05), and 9% in 
depressive symptoms at Time 2 (Fchange (1, 25) = 2.92, p ≤.05). Examination of Tolerance and 
VIF of all regression analyses revealed no problems of multicollinearity. After controlling for 
multiple comparisons, all of the initially identified significant associations remained 
statistically significant, except for the association between acceptance and anxiety symptoms 
at Time 1 (false discovery rate of 11%) (Benjamini & Hochberg, 1995; Benjamini et al., 
2006). 
Role of acceptance (Time 1) in health-related quality of life (Time 1 and 2) 
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Table 3 summarizes the results regarding quality of life. Acceptance was not related 
to physical functioning at both Time 1 and 2. Furthermore, more acceptance was related to 
better role functioning (β = .32, t = 2.20, p < .05, 95% CI [.11, 2.67]) at Time 1, but not Time 
2. Acceptance at Time 1 accounted for an additional variance of 10% in role functioning at 
Time 1 (Fchange (1, 37) = 4.83, p < .05). More acceptance was also related to better emotional 
functioning (β = .34, t = 2.18, p < .05, 95% CI [.10, 2.68]) at Time 1, but not Time 2. 
Acceptance at Time 1 accounted for an additional variance of 9% in emotional functioning at 
Time 1 (Fchange (1, 36) = 4.74, p < .05). Finally, more acceptance was also related to better 
social functioning (β = .48, t = 3.12, p < .01, 95% CI [.60, 2.84]) at Time 1, but not Time 2. 
Acceptance at Time 1 accounted for an additional variance of 18% in social functioning at 
Time 1 (Fchange (1, 37) = 9.70, p < .01). Examination of Tolerance and VIF of all regression 
analyses revealed no problems of multicollinearity. After controlling for multiple 
comparisons, all of the initially identified significant associations remained statistically 
significant (Benjamini & Hochberg, 1995; Benjamini et al., 2006).  
Discussion 
This study is the first to provide insights in the relationship between acceptance and 
well-being in CF, measured at different time points. The current findings are in line with 
those from a previous study on acceptance in adolescents and young adults with CF (Casier et 
al., 2008). This study extends research by incorporating health-related quality of life and 
investigating the relationships prospectively.  
Consistent with previous research (Casier et al., 2008; McCracken & Vowles, 2008; 
Van Damme et al., 2006), our findings reveal that greater acceptance was related to less 
depressive symptoms measured at the same point in time, and 6 months later. Contrary to our 
expectations and to research in chronic pain (see McCracken & Eccleston, 2005), acceptance 
was not related to anxiety symptoms at Time 1 and 2. This lack of association may most 
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likely be due to our small sample size. It also may reflect the relatively low levels of anxiety 
symptoms and high levels of acceptance in the current sample. Moreover, it is possible that 
acceptance is rather related to illness-specific than to general anxiety (McCracken & 
Eccleston, 2005). The significant relationship between acceptance and depressive symptoms 
at both Time 1 and 2 is in line with the conceptualisation of acceptance. An important feature 
of acceptance is to resist the idea that acceptance of illness is a sign of weakness, failure, 
helplessness, or inferiority (Risdon, Eccleston, Crombez, & McCracken, 2003). Acceptance 
involves acknowledging the reality of being chronically ill without resigning or surrendering 
(Evers et al., 2001; Hayes et al., 2006; Risdon et al., 2003). The belief that illness does not 
imply the end of a meaningful life is indeed inconsistent with depressive symptoms. 
Acceptance was also related to several domains of health-related quality of life. More 
specifically, greater acceptance was related to better role, emotional, and social functioning 
measured at the same time. This is consistent with research in other chronic conditions such 
as chronic pain, chronic fatigue syndrome, and multiple sclerosis (Evers et al., 2001; 
McCracken & Vowles, 2008; Van Damme et al., 2006). Contrary to our expectations, 
acceptance at Time 1 was not related to physical, role, emotional, and social functioning 6 
months later. The most likely explanation for this lack of association may be the small sample 
size. Despite the lack of association with the Time 2 outcomes, the Time 1 findings are in line 
with the conceptualisation of acceptance. Acceptance includes broadening a focus upon 
illness to other domains of life. This engagement in important and achievable developmental 
goals (e.g., further education, work, hobbies), within the context of a life-shortening illness, 
seems a prerequisite for a valued life (Evers et al., 2001; Hayes et al., 2006; Risdon et al., 
2003). 
The present study contributes to the increasing support that acceptance has positive 
effects on the adjustment to chronic illness, beyond the effects of socio-demographic and 
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disease-related variables. In the context of CF, acceptance comprises the ability to face the 
demands and limitations characteristic to CF, and to reconcile to the unpredictable and 
uncontrollable nature of CF (Badlan, 2006; Evers et al., 2001; Gjengedal et al., 2003). The 
current findings indicate that acceptance is related to less depressive symptoms and better 
health-related quality life at the same time point, and to less depressive symptoms 6 months 
later. These findings suggest that the role of acceptance may be central during adolescence 
and young adulthood. Indeed, from adolescence on, CF and its burden typically become more 
severe (e.g., more frequent symptoms, more exacerbations, more disability, more intensive 
treatment) (Ernst et al., 2010). This means that the trade-off between CF-related demands and 
developmental demands (e.g., doing aerosol therapy while studying, learning a new 
language/reading books/make drawings while hospitalised, choosing a job that fits with one’s 
physical capabilities) becomes essential during this period (Badlan, 2006; Gjengedal et al., 
2003; Glasscoe & Quittner, 2008; Schwartz & Drotar, 2009). Acceptance may impact this 
trade-off as it may help adolescents and young adults with CF to keep pursuing important 
developmental goals (e.g., independence, close relationships, academic achievement, family 
life, occupation) in the development towards adulthood (Ernst et al., 2010; Gjengedal et al., 
2003). The finding that in the current sample acceptance was unrelated to disease severity 
may indicate that the effects of acceptance rather refer to the subjective experience of CF 
instead of one’s objective medical condition. 
Further research is needed to verify whether adolescents and young adults with CF 
benefit from psychological interventions developed to stimulate acceptance of disease. These 
interventions may prevent loss of well-being and/or enhance well-being when affected. 
Approaches that incorporate acceptance, such as Acceptance and Commitment Therapy 
(ACT; Hayes, 2004; Hayes et al., 2006), already exist for several conditions such as 
depression, psychosis, cancer, substance abuse, chronic pain, etcetera and reveal promising 
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results (Hayes et al., 2006; Powers, Zum Vörde Sive Vörding, & Emmelkamp, 2009; Vowles, 
Wetherell, & Sorrell, 2009). Within ACT (Hayes, 2004; Hayes et al., 2006), acceptance is 
considered as a means of increasing action that is directed toward important life goals, in 
spite of being ill (Bach & Hayes, 2002; Evers et al., 2001; Hayes et al., 2006). This may be 
particularly relevant during adolescence and young adulthood as the ultimate challenge of 
adolescents and young adults with CF is to balance the pursuit of CF-related goals (i.e., 
disease management) with the pursuit of other important developmental goals (e.g., 
independence, close relationships, academic achievement, family life, occupation) (Badlan, 
2006; Gjengedal et al., 2003; Glasscoe & Quittner, 2008; Schwartz & Drotar, 2009). By 
acknowledging the reality of having CF without struggle or resignation, by believing that CF 
does not imply the end of a meaningful life and, by choosing actions that stimulate to strive 
for important developmental goals despite having CF, a meaningful life and well-being can 
be sustained (Ernst et al., 2010; Hayes et al., 2006; Risdon et al., 2003). In this context, it 
may be useful to consider ACT (Hayes, 2004; Hayes et al., 2006) for individuals with CF. 
However, to determine the usefulness of ACT (Hayes, 2004; Hayes et al., 2006) for 
adolescents and young adults with CF it is necessary to (a) further investigate the role of 
acceptance and related processes in the context of CF, (b) identify factors that influence 
acceptance, (c) modify existing ACT (Hayes, 2004; Hayes et al., 2006) approaches for 
individuals with CF, (d) conduct feasibility studies, and (e) conduct randomized controlled 
trials (Gauthier et al., 2009; Glasscoe & Quittner, 2008). Furthermore, as male 
adolescents/young adults and adolescents/young adults with higher disease severity 
demonstrated worse outcomes on particular aspects of well-being, special attention should be 
paid to these adolescents’ and young adults’ well-being. 
There are some limitations to this study. First, the sample size of the present study 
was small and consequently it is possible that small and medium effects remained undetected. 
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At Time 1, the current study only had sufficient power to detect large effects. At Time 2, 
power was low, even for the detection of large effects. Furthermore, we controlled for the 
corresponding Time 1 dependent variable in the regression analyses for the Time 2 outcomes. 
As the Time 1 dependent variables captured a great amount of the variance in the Time 2 
outcomes, this may be another reason for the null findings for anxiety and health-related 
quality of life at Time 2. Second, part of our findings are cross-sectional and therefore do not 
indicate causal effects. The prospective part of the current study is an advancement on cross-
sectional findings, but only provides a first indication of the long-term effects of acceptance. 
To truly investigate long-term effects, future research should include measurements at, at 
least, 3 consecutive time points. Third, adolescents and young adults reported on average a 
relatively good well-being. As previous research often reports worse levels of well-being for 
adolescents and young adults with CF in comparison with healthy peers (Goldbeck & 
Schmitz, 2001; Quittner et al., 2008; Pfeffer et al., 2003), it cannot be assumed that the 
current findings apply to the general population of adolescents and young adults with CF. 
Further research in more diverse samples is needed to generalise the current findings. Fourth, 
40 of 64 adolescents and young adults consented to participate. As this may reflect sample 
bias, we should be careful in generalising our results to other samples. Of the 24 non-
participants, 2 declined participation because they did not want to be unnecessarily 
confronted with their CF, what may point to a lack of acceptance. As the mean score for 
acceptance was quite high in the current sample, it is possible that the current findings may 
not generalize to samples who score lower on acceptance. Fifth, the questionnaires were 
administered in two different ways: during a house visit under the supervision of a research 
assistant at Time 1 and after receiving the questionnaires by mail at Time 2. It is possible that 
this difference in approach may have affected our results (e.g., low response rate at Time 2). 
Sixth, acceptance was only measured once. As a consequence, we were unable to detect 
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possible changes in acceptance and to identify if changes in acceptance over time concur with 
changes in well-being. Seventh, reliabilities for role functioning (Time 2) and social 
functioning (Time 1) of the CFQ-R Teen/Adult Version were quite low. Therefore, the results 
for these outcomes should be interpreted with caution. Eighth, acceptance, anxiety and 
depressive symptoms, and health-related quality of life were only assessed using self-report 
scales. A multi-method approach (e.g., objective indicators of health-related quality of life, 
ratings by parents, caregivers, or nurses) would contribute to the generality of the current 
findings. What concerns acceptance, more instruments should be developed that are usable in 
individuals with CF or chronic conditions in general, and focus more particular on certain 
facets of acceptance such as acceptance of difficult thoughts and feelings related to illness 
and the choice for action driven by important life goals despite being ill. These instruments 
could be based on the Acceptance and Action Questionnaire (AAQ; Hayes, et al., 2004), a 
generic measure that assesses ACT processes such as acceptance, values-based action, and 
psychological flexibility. The AAQ has already been adjusted for specific conditions such as 
chronic pain (Chronic Pain Acceptance Questionnaire; McCracken, Vowles, & Eccleston, 
2004) and diabetes (Acceptance and Action Diabetes Questionnaire; Gregg, 2004, in Hayes et 
al., 2004), but not yet for CF. 
To our knowledge, this is the first prospective analysis of the role of acceptance in 
anxiety and depressive symptoms, and health-related quality of life of adolescents and young 
adults with CF. The promising findings from this study indicate that acceptance may play a 
protective role in the well-being of these adolescents and young adults. These encouraging 
results stimulate to replicate the current findings and to investigate other processes related to 
acceptance such as the pursuit of important developmental goals. The relationship between 
acceptance and the pursuit of important developmental goals has, to our knowledge, not yet 
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been studied. Future research should address this relationship and should examine if the 
relationship between acceptance and well-being is mediated by goal pursuit. 
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Table 1. Means (M), standard deviations (SD), internal consistency (Cronbach’s α) and Pearson product-moment correlations of acceptance (Time 1), anxiety, depression, 
physical functioning, role functioning, emotional functioning, and social functioning. Correlation coefficients above the diagonal are at Time 1, coefficients beneath are with 
the outcomes measured at Time 2. 
 Time 1 
M(SD)               α 
Time 2 
M(SD)               α 
 
1           
 
2 
 
3 
  
4 
 
5 
 
6 
 
7 8 9 
 
10 
1. Age 18.40 (2.87) - 18.70 (2.80) - -  .73* -.45* -.03  .02  .10 -.06 -.22 -.21  .05 
2. Time since diagnosis 16.84 (3.82) - 16.99 (4.07) -  .69* - -.43* -.07 -.03  .17 -.08 -.16 -.28* -.02 
3. Disease severity 83.01 (19.7) - 84.26 (16.34) - -.31 -.36* - -.10 -.14 -.21  .32*  .34*  .14  .07 
4. Acceptance 18.55 (4.16) .90 - - -.14 -.14 -.16 - -.29* -.35*  .15  .29*  .45*  .54* 
5. Anxiety  4.88 (3.49) .71 3.79 (4.04) .71  .18  .06 -.27 -.12     -  .49* -.49* -.56* -.61* -.44* 
6. Depression  1.53 (2.05) .73 1.07 (2.96) .76  .12 -.03 -.03 -.35*  .65* - -.52* -.58* -.57* -.53* 
7. Physical functioning  81.46 (20.04) .92 85.71 (13.82) .84 -.18 -.23  .54*  .05   -.41* -.25 -  .50* .59* .39* 
8. Role functioning 83.13 (17.95) .81 85.42 (11.02) .37 -.28 -.05  .36* -.08 -.16 -.14  .36* - .55* .32* 
9.Emotional functioning 74.17 (16.82) .63 76.19 (12.63) .55 -.10 -.01  .22  .05 -.51* -.22  .50*  .24 - .68* 
10. Social functioning 71.39 (14.97) .44 74.01 (13.70) .59  .00  .11  .22  .34* -.42* -.65*  .38*  .22  .43* - 
One-tailed significance test 
*p < .05 
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Table 2. Hierarchical regression analyses of acceptance at Time 1 and anxiety and depression at Time 1 and 2.  
Dependent variable Step Predictor β R² ∆R² Adj. R² 
Anxiety (Time 1) 1 Acceptance (Time 1) -.29* .08* .08* .06* 
Depression (Time 1) 1 Acceptance (Time 1) -.35* .13* .13* .10* 
Anxiety (Time 2) 1 Anxiety (Time 1)  .63* .39* .39*  .37* 
  2 Acceptance (Time 1)  .01 .39 .00  .34 
Depression (Time 2) 1 Depression (Time 1)  .31* .13* .13*  .10* 
 2 Acceptance (Time 1) -.31* .22* .09*  .16* 
 
One-tailed significance test 
*p < .05 
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Table 3. Hierarchical regression analyses of acceptance at Time 1 and physical, role, emotional, and social 
functioning at Time 1 and 2.  
Physical functioning (Time 2) 1 Disease severity   .41* .29* .29*  .26* 
 2 Physical functioning (Time 1)  .56* .59* .31*  .56* 
 3 Acceptance (Time 1)  .09 .60 .01  .55 
Role functioning (Time 2) 1 Disease severity   .26 .13* .13*  .09* 
 2 Role functioning (Time 1)  .32 .22* .09*  .16* 
 3 Acceptance (Time 1)  -.01 .22* .00*  .12* 
Emotional functioning (Time 2) 1 Emotional functioning (Time 1)  .56* .27* .27*  .24* 
  2 Acceptance (Time 1) -.13 .29 .02  .23 
Social functioning (Time 2) 1 Social functioning (Time 1)  .73* .56* .56*  .55* 
 2 Acceptance (Time 1)  .06 .57 .00  .53 
 
One-tailed significance test 
*p < .05
 
Dependent variable Step Predictor β R² ∆R² Adj. R² 
Physical functioning (Time 1) 1 Disease severity   .34* .10* .10*  .08* 
 2 Acceptance (Time 1)  .19 .14 .03  .09 
Role functioning (Time 1) 1 Disease severity   .37* .11* .11*  .09* 
 2 Acceptance (Time 1)  .32* .22* .10*  .17* 
Emotional functioning (Time 1) 1 Gender -.20 .21* . 21*  .17* 
  Time since diagnosis -.28*     
  2 Acceptance (Time 1)  .34* .30* .09*  .24* 
Social functioning (Time 1) 1 Gender -.14 .12* .12*  .10* 
 2 Acceptance (Time 1)  .48* .31* .18*  .27* 
